+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical and pathological studies of cyclosporin-treated kidney transplant recipients . Second report: Study of 180 graft biopsies



Clinical and pathological studies of cyclosporin-treated kidney transplant recipients . Second report: Study of 180 graft biopsies



Nihon Jinzo Gakkai Shi 30(7): 875-884




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039564968

Download citation: RISBibTeXText

PMID: 3074202


Related references

Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function. Nihon Jinzo Gakkai Shi 30(7): 865-873, 1988

Early cyclosporine a withdrawal in kidney transplant recipients under a sirolimus-based immunosuppressive regimen: pathological study of graft biopsies at 1-year posttransplant. Transplantation Proceedings 34(1): 92-93, 2002

Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study. American Journal of Nephrology 15(6): 493-499, 1995

Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Human Immunology 70(8): 569-573, 2009

Kidney graft survival rates in black cyclosporine-treated recipients. Collaborative Transplant Study. Transplantation Proceedings 21(6): 3918-3920, 1989

Pretransplant factors and transplant proteinuria in the prognosis of human kidney transplantation. A clinical study of 150 consecutive kidney graft recipients. Scandinavian Journal of Urology and Nephrology 16: Suppl 16:1, 1972

Kaposi's sarcoma in kidney transplant recipients treated with cyclosporin. British Journal of Dermatology 118(5): 709-714, 1988

Infectious diseases in kidney transplant recipients treated with cyclosporin. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 80(2): 175-184, 1989

Steroid withdrawal in cyclosporin A -treated liver transplant recipients Pathological and biochemical assessment. Hepatology 32(4 Pt 2): 597A, 2000

Lethal graft vs. host disease in cyclosporin a treated bone marrow transplant recipients. Experimental Hematology 12(Suppl. 15): 72, 1984

Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood. Bmj 297(6653): 888-890, 1988

Elevated cyclosporin metabolites in diltiazem treated kidney transplant recipients. Kidney International 33(1): 446, 1988

Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A. Clinical and Experimental Immunology 85(2): 326-330, 1991

Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome. Transplantation Proceedings 37(2): 705-708, 2005